矢状窦旁脑膜瘤多学科治疗的长期结局
该单机构回顾性研究纳入2003至2011年192例符合入选标准的矢状窦旁脑膜瘤连续患者,评估肿瘤特征、治疗方式与长期结局。WHO I级肿瘤中全切除与更好无进展生存显著相关,而次全切除后辅助放疗未获益;新发高级别肿瘤中辅助放疗与更长总生存显著相关。作者认为切除程度、肿瘤级别和复发状态可指导治疗决策。
要点
- WHO I级矢状窦旁脑膜瘤中,全切除与更好无进展生存显著相关(P=0.023)。
- WHO I级次全切除患者中,辅助放疗未带来获益(P=0.215)。
- 新发高级别肿瘤中辅助放疗与更长总生存显著相关(P=0.013)。
核心结论
- 矢状窦旁脑膜瘤为异质性肿瘤,高级别肿瘤比例较高且常表现侵袭性临床行为。
- 低级别肿瘤从根治性切除中获益,而新发高级别肿瘤未从根治性切除中获益。
- 辅助放疗显著延长新发高级别肿瘤的总生存,但未影响次全切除低级别肿瘤的生存。
- 高级别复发肿瘤的长期结局不佳;切除程度、肿瘤级别和复发状态可指导治疗决策。
研究设计与样本
- 单机构回顾性综述,采用限制性入选标准以减少选择偏倚。
- 纳入2003至2011年该综合医院192例符合入选标准的连续矢状窦旁脑膜瘤患者。
主要发现
- 131例(68.2%)为WHO I级,40例(20.8%)为II级,21例(10.9%)为III级。
- 组织学级别越高与H3K27三甲基化丢失相关(P=0.000)。
- WHO I级中全切除与更好无进展生存显著相关(P=0.023),次全切除后辅助放疗未获益(P=0.215)。
- 新发高级别(WHO II和III级)37例中,辅助放疗与更长总生存显著相关(P=0.013),全切除与次全切除间无差异(P=0.654)。
- 复发高级别24例中,全切除联合辅助放疗提高无进展生存(P=0.005)。
临床怎么用
- 作者认为切除程度、肿瘤级别和复发状态可指导矢状窦旁脑膜瘤的治疗决策。
- 作者指出低级别肿瘤从根治性切除中获益,而新发高级别肿瘤未从根治性切除中获益。
- 作者指出辅助放疗显著延长新发高级别肿瘤的总生存,但未影响次全切除低级别肿瘤的生存。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: The aim of this study was to systematically analyze the clinical characteristics of a large cohort of parasagittal meningioma (PM) and to evaluate the patients' outcomes and best treatment strategies based on tumor features. METHODS: To minimize selection bias we performed a single-institutional review of PM with restricted criteria. One hundred and ninety-two consecutive patients who met criteria for inclusion were reviewed from 2003 to 2011 in our general hospital. RESULTS: A total of 131 cases (68.2%) were with WHO grade I, while grade II and grade III PMs constituted 40 (20.8%) and 21 cases (10.9%). Higher histological grade was associated with loss of trimethylation of H3K27 (P = 0.000). For WHO grade I PMs, GTR was significantly associated with a better PFS (P = 0.023); however, adjuvant radiotherapy did not benefit patients with STR (P = 0.215). For de novo high-grade (WHO grade II and III) PMs (n = 37), adjuvant radiotherapy was associated with a significantly longer OS (P = 0.013), while no difference was observed between GTR and STR (P = 0.654). In recurrent high-grade PM patients (n = 24), GTR combined with adjuvant radiotherapy increased PFS (P = 0.005). CONCLUSIONS: This study demonstrated that PMs were a heterogeneous group of tumors with a high proportion of high-grade tumors that often displayed aggressive clinical behaviors. Low-grade PM benefited from radical resection, whereas high-grade de novo PM did not. Adjuvant radiotherapy significantly prolonged OS for high-grade primary PM, but did not impact survival of patients with subtotally resected low-grade tumors. Long-term outcome of high-grade recurrent PMs was dismal. We thus show that extent of tumor resection, tumor grade and tumor recurrent status inform therapeutic decisions for PMs.
引用
- Hua L, Wang D, Zhu H, et al. Long-term outcomes of multimodality management for parasagittal meningiomas. J Neurooncol. 2020. PMID: 32088814. doi:10.1007/s11060-020-03440-9
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。